Noam Danenberg Insider Trading $WIZP Mawson Infrastructure Group Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Noam Danenberg.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Noam Danenberg. Noam Danenberg is Chairman in Wize Pharma, Inc. ($WIZP) and Chief Executive Officer in Wize Pharma, Inc. ($WIZP) and Chief Operating Officer in Wize Pharma, Inc. ($WIZP).
Noam Danenberg in Mawson Infrastructure Group Inc.
Trading Symbol: WIZPIndustry: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
Position of Noam Danenberg: Chief Executive Officer, Chairman, Chief Operating Officer
Holdings: 3,165,705 shares
Latest Transaction: Mar 11 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Noam Danenberg in Mawson Infrastructure Group Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 11 2021 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Buy | P | 0.12 | 2,916,667 | 350,000 | 3,165,705 | 249 K to 3.2 M (+1,171.17 %) |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Option Exercise | X | 0.27 | 63,236 | 17,074 | 0 | |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Option Exercise | X | 0.16 | 173,607 | 27,777 | 0 | |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Option Exercise | X | 0.27 | 1,505,162 | 406,394 | 0 | |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Option Exercise | X | 0.16 | 125,000 | 20,000 | 0 | |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Sell | S | 0.00 | 507 | 0 | 2,804,227 | 2.8 M to 2.8 M (-0.02 %) |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Buy | X | 0.00 | 63,236 | 0 | 2,804,734 | 2.7 M to 2.8 M (+2.31 %) |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Sell | S | 0.00 | 1,447 | 0 | 2,741,498 | 2.7 M to 2.7 M (-0.05 %) |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Buy | X | 0.00 | 173,607 | 0 | 2,742,945 | 2.6 M to 2.7 M (+6.76 %) |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Sell | S | 0.00 | 12,543 | 0 | 2,569,338 | 2.6 M to 2.6 M (-0.49 %) |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Buy | X | 0.00 | 1,505,162 | 0 | 2,581,881 | 1.1 M to 2.6 M (+139.79 %) |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Sell | S | 0.00 | 962 | 0 | 1,076,719 | 1.1 M to 1.1 M (-0.09 %) |
Dec 31 2020 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Buy | X | 0.00 | 125,000 | 0 | 1,077,681 | 952.7 K to 1.1 M (+13.12 %) |
Dec 17 2019 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Option Exercise | J | 0.27 | 31,146 | 8,409 | 94,382 | |
Dec 17 2019 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Option Exercise | J | 0.27 | 1,505,162 | 406,394 | 1,505,162 | |
Dec 17 2019 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Buy | C | 0.00 | 752,581 | 0 | 952,681 | 200.1 K to 952.7 K (+376.10 %) |
Sep 16 2019 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Option Exercise | M | 0.00 | 17,500 | 0 | 122,500 | |
Sep 16 2019 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Buy | M | 0.00 | 17,500 | 0 | 142,500 | 125 K to 142.5 K (+14.00 %) |
Jun 10 2019 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Option Exercise | P | 1.10 | 173,607 | 190,968 | 173,607 | |
Apr 23 2019 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Option Exercise | P | 1.00 | 125,000 | 125,000 | 125,000 | |
Apr 23 2019 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Option Exercise | P | 1.10 | 125,000 | 137,500 | 125,000 | |
Apr 23 2019 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Option Exercise | P | 1.33 | 94,382 | 125,717 | 94,382 | |
Apr 23 2019 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Option Exercise | P | 1.11 | 265,531 | 295,058 | 265,531 | |
Apr 23 2019 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Executive Off ... | Buy | P | 1.00 | 125,000 | 125,000 | 165,100 | 40.1 K to 165.1 K (+311.72 %) |
Apr 02 2019 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chairman | Option Exercise | A | 0.00 | 140,000 | 0 | 180,100 | |
May 01 2018 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Operating Off ... | Option Exercise | A | 3.59 | 36,000 | 129,240 | 0 | |
May 01 2018 | WIZP | Wize Pharma, Inc. | Danenberg Noam | Chief Operating Off ... | Grant | A | 0.00 | 40,100 | 0 | 98,515 | 58.4 K to 98.5 K (+68.65 %) |
Page: 1